Apollo Pharmacies Maintains Growth, Remains in the Red
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Bottomline: PE-backed Apollo Pharmacies sustains revenue growth but stays in the red

Bottomline: PE-backed Apollo Pharmacies sustains revenue growth but stays in the red

By Nitesh Kumar

  • 26 May 2025
Premium
Bottomline: PE-backed Apollo Pharmacies sustains revenue growth but stays in the red
An Apollo Pharmacy in Nagpur | Credit: Wikimedia Commons

Apollo Pharmacies Ltd managed to grow its topline at a steady pace in the year through March 2025 but remained in the ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.
Advertisement

Related Articles

Premium
Gujarat Superspeciality Hospital eyes acquisition-led growth in western India

Healthcare

Gujarat Superspeciality Hospital eyes acquisition-led growth in western India

PE-backed Indira IVF and listed MosChip strike M&A deals

Healthcare

PE-backed Indira IVF and listed MosChip strike M&A deals

Premium
PAG eyes exit from healthcare portfolio firm, hires banker

Healthcare

PAG eyes exit from healthcare portfolio firm, hires banker

Pro
Aakash Healthcare nears deal to bring in PE investor

Healthcare

Aakash Healthcare nears deal to bring in PE investor

Pro
Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Healthcare

Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Premium
KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Healthcare

KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Everstone to invest $270 mn in drugmaker Apothecon

Healthcare

Everstone to invest $270 mn in drugmaker Apothecon

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW